Table 3.
Association between age and OS, SOS, and DFS among 1054 breast patients.
| HR (95% CI)* | Age(years) | |||
|---|---|---|---|---|
| Q1(22-43years) | Q2(44-50years) | Q3(51-58years) | Q4 (59-90years) | |
| OS | ||||
| Model 1 | 2.14 (0.92, 4.95) | 1 | 2.18 (0.95, 5.01) | 3.16 (1.44, 6.93) |
| Model 2 | 2.10 (0.90, 4.86) | 1 | 2.13 (0.93, 4.90) | 3.10 (1.41, 6.82) |
| Model 3 | 2.09 (0.90, 4.84) | 1 | 2.44 (1.05, 5.65) | 3.38 (1.51, 7.54) |
| BCSS | ||||
| Model 1 | 3.28 (1.07, 10.07) | 1 | 2.66 (0.85, 8.35) | 4.99 (1.72, 14.49) |
| Model 2 | 3.32 (1.08, 10.20) | 1 | 2.58 (0.82, 8.10) | 4.95 (1.70, 14.40) |
| Model 3 | 3.26 (1.06, 10.04) | 1 | 2.88 (0.91, 9.11) | 5.14 (1.74, 15.17) |
| DFS | ||||
| Model 1 | 1.88 (1.07, 3.28) | 1 | 2.21 (1.29, 3.78) | 2.22 (1.30, 3.78) |
| Model 2 | 1.89 (1.08, 3.30) | 1 | 2.11 (1.23, 3.62) | 2.20 (1.29, 3.75) |
| Model 3 | 1.90 (1.09, 3.33) | 1 | 2.22 (1.29, 3.83) | 2.29 (1.33, 3.94) |
Model 1: unadjusted. Model 2: adjusted for tumor size, molecular subtype. Model 3: adjusted for tumor size, molecular subtype, LN positive, operation type, adjuvant therapy, hormonal therapy. *Cox proportional hazards models were used to estimate HRs and 95% CIs.